AquaBounty IPO raises $65.2m for GM salmon

By Robert Outram | December 15, 2020

North American land-based salmon farmer AquaBounty Technologies has announced the closing of its public share offering (IPO), which has raised $65.2 million before expenses. The company is pioneering genetically modified (GM) salmon. AquaBounty says it intends to use the net proceeds of the offering for “general corporate purposes, including for the purchase of land and…

Read More

Benchmark Genetics signs ova deal with AquaCon

By Robert Outram | November 3, 2020

The Iceland arm of Benchmark Genetics has signed a five-year contract to supply salmon ova to fish farmer AquaCon in the US. The contract involves deliveries of genetics to the land-based facilities that AquaCon are planning to build in Maryland, with around 40 million ova due to be delivered over the five-year period. The farm…

Read More